// App-Quantinova.ai

4963 : A distinct AMP-activated protein kinase phosphorylation site is associated with metastasis and castration-resistance in prostate cancer

Researchers

Presenter

  • Melissa A. Babcook

Principal Investigators

  • Mahmut Akgul

  • Seunghee Margevicius

  • Gregory T. MacLennan

  • Pingfu Fu

  • Robert Abouassaly

  • Sanjay Gupta

Medical Centers

  • University of Toledo College of Medicine, Toledo, OH

  • University Hospitals Case Medical Center, Cleveland, OH

  • Case Western Reserve University, Cleveland, OH

Locations

  • United States

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

  • Urology

Disease

  • Metastatic castration-resistant prostate cancer

  • Prostate cancer

  • Solid malignancies

Biomarkers

  • AMP-activated protein kinase

  • Prostate specific antigen

Drug/Treatment

  • Androgen Tear

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved